Springer, 2016. — 501 p. This book presents the full range of management techniques and practices used in induction chemotherapy – both systemic and locoregional - by experienced international groups within one accessible volume. It provides the latest information on the pioneering and cutting-edge practices employed in different institutions and documents the advantages of...
Springer Science+Business Media, 2010. — 713 p. This book was put together by eminent and recognized experts in alternative medicine, medical oncology, cancer pharmacology, safety and regulatory issues, and modern cancer research. It is dedicated primarily to the medical community, health care providers, and to medical students. It brings a set of timely, indepth,and up-to-date...
Fachmedien: Springer Spektrum, 2015. — 153 p. — ISBN: 978-3-658-10160-2, 978-3-658-10161-9. Hamed Alborzinia uses the biosensor chip to monitor the metabolic and morphological changes in cancer cell lines in real time, particularly: (i) real-time measurements of basic cancer cell metabolism of different cancer cell lines; (ii) a detailed timeline of the metabolic response to...
CRC Press, 2024. — 313 p. — (Drugs and the Pharmaceutical Sciences). — ISBN 978- 1- 032- 4- 2625- 9. This volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis. It incudes conventional and advanced cancer therapies ranging from oral and parenteral...
Oxford University Press, 2010. — 80 p. Although antibiotics are among the most widely used pharmaceuticals, they are also often inappropriately and over-prescribed. Indeed there are increasing predictions that unless we moderate our use of these drugs, bacterial resistance will eventually render them useless. As there are no serious contenders to take the place of antibiotics,...
Wiley-Blackwell, 2017. — 1048 p. — ISBN: 978-1-118-90751-1. The Biology and Therapeutic Application of Mesenchymal Cells comprehensively describes the cellular and molecular biology of mesenchymal stem cells and mesenchymal stromal cells, describing their therapeutic potential in a wide variety of preclinical models of human diseases and their mechanism of action in these...
London: Academic Press, London, 2017. — 294 p. — ISBN: 0128035056, 978-0-12-803505-4, 9780128035412, 0128035412. Conquering RAS: From Biology to Cancer Therapy provides introductory knowledge on how modern RAS biology is taking shape in light of newer technological development. Each chapter is written in a manner that emphasizes simplicity and readability for both new...
Humana Press, 2010. — 765 p. — (Cancer Drug Discovery and Development). — ISBN: 978-1-4419-6614-8. The field of cancer biology and developmental therapeutics is continually evolving as new methodologies are developed and new targets are discovered. Although multiple therapeutics directly target the malignant cells these drugs rarely prevent recurrence of disease or the...
ITexLi, 2016. — 188 p. — ISBN: 9535128140 In this book, you can find out how scientists throughout the world deal with this problem. Readers will learn how to engage nature, chemical synthesis, and cell machinery to design new anticancer agents. We are in constant search for new therapeutic options to cure cancer. Nature has already been very generous in providing us different...
CRC Press, 2021. — 328 p. — ISBN 9781138712423. Differential gene regulation and targeted therapy are the critical aspects of several cancers. This book covers specific gene regulation and targeted therapies in different malignancies. It offers a comprehensive assessment of the transcriptional dysregulation in cancer, and considers some examples of transcriptional regulators as...
Academic Press, 2018. — 384 p. — (Cancer Sensitizing Agents for Chemotherapy). — ISBN: 978-0-12-812373-7. This book, Volume Two, focuses on nutraceuticals, the compounds derived from natural sources, which are usually multi-targeted as a means to overcome chemoresistance. This book discusses the role of several compounds related to nutraceuticals and chemoresistance, such as...
Springer, 2024. — 325 p. — ISBN-13 : 978-9819730001 The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers.
Academic Press, 2019. — 429 p. — (Translational Epigenetics). — ISBN: 978-0-12-812494-9. This book is the first to look at epigenetics and chemoprevention together. Although there is numerous scientific data available on how epigenetics can lead to cancer and how chemoprevention can be beneficial in the treatment of, or improvement of quality of life, together they will set an...
Oregon Medical Press, 2001. — 521 p. — ISBN: 0-9648280-1-4 This book is divided into three parts. Parts one and two examine cancer at the cellular level, and cancer at the level of the organism, respectively. After reading parts one and two, the reader will come away with a far greater understanding of what cancer is, how it comes to be, how solid tumors are formed, etc. This...
Humana Press, 2010. — 513 p. Nitric Oxide (NO) is a pleitropic, ubiquitous modulator of cellular functions. Aryl nitrite and glyceryl trinitrate, representative intravasadilators, were introduced as therapeutic agents more than a century ago for relief from acute attacks of angina. The vasodilator action is mediated by the release of NO following treatment. NO has important...
Cham, Switzerland: Springer International Publishing, 2015. — 308 p. — ISBN: 978-3-319-13610-3, 978-3-319-13611-0. Nitric Oxide and Cancer: Pathogenesis and Therapy provides the latest research and applications of nitric oxide (NO) in cancer written by experts in the field. The volume reviews significant advances in the biochemical and molecular biology of NO-mediated effects...
Academic Press, 2017. — 238 p. — (Cancer Sensitizing Agents for Chemotherapy). — ISBN: 978-0-12-811020-1. This book, Volume One is the first book to describe several reviews by authoritative scientists and clinicians on novel findings in the reversal of drug resistant cancers by the combination treatment of Nitric Oxide and sub toxic concentrations of chemotherapeutic drugs...
Humana Press, 2008. — 431 p. — ISBN: 978-1-934115-29-9. Targeted therapies include monoclonal antibodies, cell-mediated immunotherapy, gene immunotherapy, and the development of inhibitors interfering with survival antiapoptotic signaling pathways in cancers. While these novel approaches have significantly improved the outcome of many cancer patients, there remains a major...
Springer Berlin Heidelberg New York, Springer-Verlag Berlin Heidelberg 2007. — 457 p. — ISSN: 1862-2461, ISBN10: 3-540-33119-0, ISBN13: 978-3-540-33119-3. Anti-hormone Therapy: Principles of Endocrine Therapy of Cancer. Inhibition of Growth Factor Signaling by Small-Molecule Inhibitors of ErbB, Raf, and MEK. Farnesyl Protein Transferase Inhibitors: Medicinal...
Springer Science & Business Media, 2006. — 352 p. Over recent decades, combined modality treatment has drastically improved the cure rates for various malignant tumors. Further progress is expected through the design of sound combinations involving recently developed drugs. The first part of this book summarizes the rationale and the preclinical data for combined treatment with...
Karger Publishers, 2021. — 96 p. Diffuse large B-cell lymphoma (DLBCL) is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to improve outcomes in these patients. As such,...
Springer, 2022. — 330 p. — ISBN 978-3-031-10838-9. This book aims to address the infusion sequence of the main protocols used in the treatment of varied solid cancers. Since an inadequate infusion sequence can compromise the patient's treatment, this work will provide support to professionals working in the field of oncology in assessing each chemotherapy infusion sequence.The...
5th Edition. - Lippincott Williams & Wilkins, 2011. - 838 p. - Updated to include the newest drugs and those currently in development, Cancer Chemotherapy and Biotherapy, Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological...
Boston: Wolters Kluwer, 2019. — 1004 p. Thoroughly revised and reformatted, the sixth edition of Cancer Chemotherapy, Immunotherapy and Biotherapy reflects recent significant changes in cancer treatment. This newly streamlined edition contains full-color illustrations, more tables for quick reference, and new immunotherapy and molecular targeted therapy content that brings you...
Pan Stanford Publishing, 2019. — 465 p. — ISBN: 9789814774864 This book deals with the emerging concept that certain pathogenic bacteria and viruses, when infecting people with cancer, actively fight tumors, allowing their regression. Although such observations go back more than 100 years, use of specific bacterial strains, or viruses, usually genetically modified with known...
World Scientific Publishing Company, 2017. — 458 p. This unique book deals with both inflammation and cancer in a single source of publication. They are seldom grouped together although it has been known that both diseases are closely associated, particularly in the gastrointestinal tract and liver. As the book touches on two such major areas of diseases in humans, it should be...
Jones & Bartlett Learning, 2015. — 683 p. Principles of Cancer Chemotherapy Chemotherapeutic and Biologic Drugs Guidelines for Chemotherapy and Dosing Modifications Common Chemotherapy Regimens in Clinical Practice Antiemetic Agents for the Treatment of Chemotherapy-Induced Nausea and Vomiting
Jones & Bartlett Learning, 2024. — 970 p. Editors Contributing Authors Preface Acknowledgments Principles of Cancer Chemotherapy Chemotherapeutic and Biologic Drugs Guidelines for Chemotherapy and Dosing Modifications Common Chemotherapy Regimens in Clinical Practice Antiemetic Agents for the Treatment of Chemotherapy-Induced Nausea and Vomiting Index
New York: Jones & Bartlett Learning, 2018. — 703 p. Written by world-class experts in clinical cancer therapeutics, Physicians' Cancer Chemotherapy Drug Manual 2019 provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens--both on- and off-label--for the treatment of all the major cancers. Half Title Page. Title Page. Copyright. Editors....
18th edition. — Jones & Bartlett Learning, 2019. — 655 p. — ISBN: 978-1284144963 Completely revised and updated for 2018, the Physicians' Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a...
21st edition. — Jones & Bartlett Learning, 2021. — 836 p. — ISBN 9781284230130. Completely revised and updated for 2021, the Physicians’ Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a...
Nova Science Publishers, 2016. — 335 p. This book represents the efforts of young oncologists, haematologists, pharmacists and oncology nurses who are highly motivated and encouraged by the significant development of new effective anticancer drugs. Since the discovery of antimetabolites and alkylating agents in the 1940s and 1950s, many new products have been introduced into our...
Humana Press, 2001. — 275 p. The association of matrix metalloproteinases (MMPs)-enzymes that disrupt the body's normal repair functions-with several diseases, including growing and invasive tumors, holds the tantalizing promise that their inhibiton might have therapeutic value. In Matrix Metalloproteinase Inhibitors in Cancer Therapy, cutting-edge investigators review the current...
CRC Press, Taylor & Francis Group, 2017. — 204 p. — (Chapman & HALL/CRC. Mathematical and Computational Biology Series) — ISBN: 1466551348. Physical oncology has the potential to revolutionize cancer research and treatment. The fundamental rationale behind this approach is that physical processes, such as transport mechanisms for drug molecules within tissue and forces...
Cham, Switzerland: Humana Press, 2015. — 591 p. — (Cancer Drug Discovery and Development 83). — ISBN: 978-3-319-14150-3, 978-3-319-14151-0. PARP Inhibitors for Cancer Therapy provides a comprehensive overview of the role of PARP in cancer therapy. The volume covers the history of the discovery of PARP (poly ADP ribose polymerase) and its role in DNA repair. In addition, a...
Cham, Switzerland: Springer, 2015. — 292 p. — ISBN: 3319191438, 9783319191430. Provides a comprehensive review of the most current findings on the efficacy of bioactive essential oils as a possible therapeutic for cancer Appeals to cancer researchers and those interested in natural products, medicinal chemistry and pharmacology Explores the chemical and biological mechanisms of...
Springer, 2013. — 659 p. This book is a comprehensive handbook designed for quick reference by medical oncologists on the side-effects of cancer therapy drugs, including the chemotherapeutic drugs. Organised by organ system, it will list the toxicity, side-effects and measures of prevention pertaining to each type of drug used in cancer therapy. The most dangerous side-effects...
2nd edition. — Springer, 2018. — 512 p. — ISBN: 978-3-319-70252-0 This is the second edition of a well-received book that reflects the state of the art in cancer medical therapies and their side-effects, including immunotherapy and chemotherapeutic drugs. All chapters have been fully updated to include all the latest progress in drug discovery such as targeted therapies for each...
Springer New York, 2014. — 256 p. Cancer incidences increase in people living with HIV/AIDS. Over 2 million people currently live with HIV/AIDS in the US. This number will increase as HAART prolongs the average lifespan and as (at least in some states) the number of new HIV infections increase again. As this population ages their incidence rates for cancer will increase, as well....
Springer, 2013. — 952 p. Image-Guided Cancer Therapy: A Multidisciplinary Approach provides clinicians with in-depth coverage of the growing, dynamic field of interventional oncology. Combining the knowledge of expert editors and authors into one powerhouse reference, this book looks at tumor ablation, HIFU, embolic therapies, emerging technologies, and radiation therapy...
Demos Medical Publishing, 2020. — 301 p. — ISBN 978-0-8261-6203-8. Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs provides a one-stop guide to the essential basic and clinical science of all the effective, life-prolonging drug therapies in oncology. From traditional cytotoxic agents to targeted genomic, epigenomic, hormonal, and immunotherapeutic agents, this...
Humana Press, 2009. — 296 p. Supportive care of the cancer patient begins with the diagnosis of cancer and terminates with the end of life. The supportive care is for symptoms related to the cancer and/or its treatment; physical, psychosocial and emotional issues associated with the cancer. Patients with cancer, in general, are living longer. Even those with advanced, metastatic...
Springer, 2022. — 304 p. — ISBN 978-981-16-7478-5. The book provide up-to-date information on clinical application of microwave ablation for limb salvage in bone tumors. First chapters briefly introduce clinical diagnosis, stage, amputation and limb salvage surgery of bone tumors. In the following chapters, detailed procedure of microwave ablation of bone tumors in various...
Springer, 2018. — 402 p. — (Resistance to Targeted Anti-Cancer Therapeutics 17). In this book, expert authors revisit the most relevant aspects of these therapies, with special emphasis on molecular mechanisms and clinical effects of resistance. The knowledge of the underlying mechanisms involved in tumor resistance to target therapies is of paramount importance because they...
2nd Edition. — Humana Press, 2014. — 828 p. There are many steps on the road from discovery of an anticancer drug to securing its final approval by the Food and Drug Administration. In this thoroughly updated and expanded second edition of the Handbook of Anticancer Pharmacokinetics and Pharmacodynamics, leading investigators synthesize an invaluable overview of the experimental...
Demos Medical, 2011. — 256 p. Manual of Cancer Treatment Recovery presents the first comprehensive program to guide the recovery from cancer and its treatment. The Manual helps you, other practitioners, and your staff members plan early intervention and promote healing right from the start, before distressing symptoms begin. Manual of Cancer Treatment Recovery teaches how to guide...
Demos Medical Publishing, 2011. — 228 p. Manual of Cancer Treatment Recovery presents the first comprehensive program to guide the recovery from cancer and its treatment. The Manual helps you, other practitioners, and your staff members plan early intervention and promote healing right from the start, before distressing symptoms begin. Manual of Cancer Treatment Recovery teaches...
Springer International Publishing, Cham, Switzerland, 2016, 188 pages, ISBN: 978-3-319-46090-1, 978-3-319-46091-8. Resistance to Targeted Anti-Cancer Therapeutics. The volume will provide readers with a primer on tyrosine kinase signaling and its importance in cancer. The reader will be first introduced to common denominators of small-molecule and antibody-derived inhibitors,...
Springer, 2019. — 490 p. — ISBN: 978-3-030-28890-7 This book is a state-of-the-art overview of cancer regional therapy (CRT) for the surgeons and interventional radiologists active in CRT development and research. The goals of this book are 1) to review the theory and practice of cancer regional therapies including pharmacology, devices, techniques, and workflow, 2) illustrate...
Springer, 2019. — 1711 p. — ISBN: 978-3-030-28891-4 This book is a state-of-the-art overview of cancer regional therapy (CRT) for the surgeons and interventional radiologists active in CRT development and research. The goals of this book are 1) to review the theory and practice of cancer regional therapies including pharmacology, devices, techniques, and workflow, 2) illustrate...
CRC Press, 2023. — 171 p. The book deals only with HDAC inhibitors from natural origins including bacteria, fungi, marine organisms and, notably, from diverse plant sources. This book is unique in the sense that it is the only book that discusses wholly and solely HDAC inhibitors of natural origin in the context of cancer chemotherapy. Another peculiar feature of this book is...
Adis, 2015. — 410 p. — ISBN: 978-3-319-12252-6, 978-3-319-12253-3. Presents multi-targeted approach to treating cancer Provides rationale for treatment Presents targeted approaches to treating, preventing and managing cancer In this book, clinicians and basic scientists from USA, India, and other countries discuss the rationales and clinical experiences with targeted approaches...
Springer, 2020. — 69 p. — ISBN: 978-3-030-40966-1. This atlas contains a large number of original photographs illustrating the anatomy, research methods, and structural features of the structure of the lymphatic apparatus in oncological diseases. The tissue complexes of the axillary region have been studied in detail. The lymphatic maps of the axillary region in cancer are...
2nd Edition. — CRC Press, 2014. — 485 p. Since the last edition of this book, major advances have been made in our understanding of key pathways that control tumor progression. This has led to the development of new anticancer agents that have the ability to block the activity of proteins involved in neoplastic cell development and proliferation. Targeted Therapies in Oncology,...
Springer US, 2009. — 380 p. — ISBN: 978-0-387-77103-8. Late Effects of Treatment for Brain Tumors reviews the development of the medical team's awareness of late effects of brain tumor treatment and an overview of brain tumor survivorship. It reviews the late effects by topic and by organ systems, educates, and provides guidelines for follow up and interventions for patient...
London: Academic Press, 2015. — 721 p. — (Translational Epigenetics Series). — ISBN: 0128002069, 978-0-12-800206-3. Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also provides valuable information for researchers, academics,...
2nd edition. — Academic Press, 2023. — 773 p. — (Translational Epigenetics Series). — ISBN 978-0-323-91367-6. Epigenetic Cancer Therapy, Second Edition provides a comprehensive discussion of healthy and aberrant epigenetic biology, along with new discoveries to improve our understanding of cancer epigenetics and therapeutics. The book encompasses large-scale intergovernmental...
Cham, Switzerland: Springer International Publishing, 2015. — 490 p. — ISBN: 978-3-319-20749-0, 978-3-319-20750-6. Examines the roles and functions of sphingolipids in the development, progression and treatment of various cancers Explores the use of innovative approaches for quantitative analysis and imaging which could have the potential benefit of helping to develop novel...
CRC Press, 2018. — 314 p. This book provides researchers and practitioners with a unique collection of current research on the role of vitamins and micronutrients in cancer prevention and treatment. New theories are discussed, including a hypothesis that dietary factors may protect against genetically predisposed cancers. Mechanisms by which different vitamins and minerals...
Springer, 2021. — 652 p. — ISBN 978-3-030-74034-4. Today's consumers are looking for food products with health-promoting roles in addition to nutritional benefits. With current research showing that nutraceuticals and functional foods rich in specific bioactives may have chemopreventative effects, these products are increasingly popular. However, while much in the literature...
Springer, 2021. — 652 p. — ISBN 978-3-030-74034-4. Today's consumers are looking for food products with health-promoting roles in addition to nutritional benefits. With current research showing that nutraceuticals and functional foods rich in specific bioactives may have chemopreventative effects, these products are increasingly popular. However, while much in the literature...
Springer, 2013. — 503 p. — ISBN: 978-1-60327-968-0. Cancer remains a major cause of death worldwide. With modern therapy, millions of patients can expect (or at least hope) to be cured. With the passage of time, a proportion of these cancer survivors experience recurrence. Some die and some are rescued by further interventions. Some sustain complications of treatment which are...
Humana Press, 2002. — 423 p. Millions of people are now successfully using hormone antagonists for the treatment of endocrine-dependent cancers. In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying these targeted treatments, assess the actions of new and established agents, and illustrate the new...
Springer, 2015. — 308 p. — (Medical Radiology - Diagnostic Imaging). — ISBN: 978-3-319-12840-5. Depending on their mechanism of action, the cytotoxic and targeted drugs and radiotherapy employed in oncologic treatment may cause complications and toxicities in many organ systems, with variable radiologic presentations. This comprehensive and excellently illustrated book covers...
Springer, 2020. — 314 p. — (Springer Series on Atomic, Optical, and Plasma Physics 115). — ISBN 978-3-030-49965-5. This book, written by key researchers in the field, provides a comprehensive analysis and overview of the state of the art of plasma-based cancer therapy. Recent progress in atmospheric plasmas has led to non-thermal or cold atmospheric plasma (CAP) devices with...
4th edition. — Wolters Kluwer, 2016. — 1151 p. — ISBN: 9781469889979. This unique, full-color reference offers a total team approach to radiation oncology treatment planning, incorporating the newest imaging techniques and offering a comprehensive discussion of clinical, physical, biological and technical aspects. A clear focus on the application of physical and clinical...
4th ed. — Lippincott Williams & Wilkins, 2016. — 648 p. — ISBN: 978-1-469-88997-9. This unique, full-color reference offers a total team approach to radiation oncology treatment planning, incorporating the newest imaging techniques and offering a comprehensive discussion of clinical, physical, biological and technical aspects. A clear focus on the application of physical and...
9th edition. — Wolters Kluwer, 2016. — 954 p. — ISBN: 9781496305558 For more than 30 years, Skeel’s Handbook of Cancer Therapy (formerly Handbook of Cancer Chemotherapy ) has been the resource of choice for current, reliable information on cancer treatment for most adults. The 9th Edition reflects recent significant advances in the systemic treatment of cancer, including...
Springer Science+Business Media, Dordrecht, Netherlands, 2016, 276 pages, ISBN: 978-94-024-0842-3, 978-94-024-0844-7. Presents comprehensive charts of important discoveries of scientific endeavours on cancer research. Includes timelines and conceptual cartoons for wide spectrum of anticancer drugs. Provides a novel perspective for the research on cell network according to the...
Humana Press, 2013. — 248 p. — (Cancer Drug Discovery and Development). This volume will cover the natural products as they relate to cancer chemotherapy. The topics will include history and current status , recent launches, new clinical candidates and approved drugs directly derived from natural products, current and future cancer target opportunities for natural products,...
Springer, 2022. — 671 p. — (Biology of Extracellular Matrix 11). — ISBN 978-3-030-99708-3. This book introduces the most important and best studied extracellular and pericellular molecules of the tumor microenvironment. It gives a comprehensive overview of their role in tumor development and cancer progression. Twelve chapters deal with the biochemical and biophysical...
Springer, 2022. — 493 p. — (Biology of Extracellular Matrix 11). — ISBN 978-3-030-99707-6. This book introduces the most important and best studied extracellular and pericellular molecules of the tumor microenvironment. It gives a comprehensive overview of their role in tumor development and cancer progression. Twelve chapters deal with the biochemical and biophysical...
Nova Science Publishers, 2014. — 164 p. Since the year 2000, exciting developments in cancer therapy have occurred. For decades in the 20th century, the hallmark of medical treatment for cancer had been cytotoxic chemotherapy, with drugs targeting rapidly dividing cells, including cancer cells but also certain normal tissues. As a result, many patients experienced the "classic"...
Springer, 2021. — 798 p. — (Cancer Treatment and Research). — ISBN 978-3-030-81526-4. This book presents a timely and multidisciplinary update on the modalities currently available for treating the most feared symptom of patients diagnosed with cancer. The various cancer pain syndromes are explored in detail, covering those related directly to malignancy and those due to the...
Springer, 2021. — 298 p. — (Cancer Treatment and Research). — ISBN 978-3-030-81525-7. This book presents a timely and multidisciplinary update on the modalities currently available for treating the most feared symptom of patients diagnosed with cancer. The various cancer pain syndromes are explored in detail, covering those related directly to malignancy and those due to the...
Springer Netherlands, 2014. — 344 p. Microwave ablation is a simple, affordable, and highly precise technique. After its successful application in treating liver tumors, it is now widely used to combat renal tumors, adrenal tumors, thyroid nodes, uterine fibroids and other solid tumors. This book presents 40 successful cases of treating these diseases. A series of picture before...
Humana Press, 2008. — 680 p. — (Contemporary Hematology) — ISBN: 978-1-934115-82-4 Therapeutic options for patients with myeloma have radically changed over the past ten years. Myeloma Therapy: Pursuing the Plasma Cell provides updated various treatment options for patients with myeloma, with focus on the emerging and speculative aspects of myeloma therapy. Written by clearly...
Springer, 2023. — 153 p. — ISBN 978-3-031-36260-6. The book thoroughly presents Transarterial Chemoembolization (TACE), a procedure representing the standard of care for several clinical oncological indications.Thanks to the considerable technological advances in the available instrumentation (guidewire, microcatheter, guiding imaging modalities) as well as the different...
New York: Springer, 2021. — 265 p. This book comprehensively examines chemotherapy-induced peripheral neuropathy (CIPN), a common dose-limiting condition that negatively affects both the quality of life of cancer patients and disease outcomes. CIPN remains a challenging area for both clinical care and research, as there are multiple unresolved issues. Written by leading...
Springer Science & Business Media, 2009. — 392 p. The extravasation of cytotoxic agents can result in severe local tissue damage and medical emergencies during tumour therapy. This revised compendium is intended to help clinicians assess any situation speedily and with certainty. The general section of the book includes topics such as predisposition, prevention, type of harm,...
2nd edition. — Springer Science & Business Media, 2009. — 392 p. The extravasation of cytotoxic agents can result in severe local tissue damage and medical emergencies during tumour therapy. This revised compendium is intended to help clinicians assess any situation speedily and with certainty. The general section of the book includes topics such as predisposition, prevention,...
Boca Raton: CRC Press, 2022. — 424 p. This book presents an overview of the current status of translating the RNAi cancer therapeutics in the clinic, a brief description of the biological barriers in drug delivery, and the roles of imaging in aspects of administration route, systemic circulation, and cellular barriers for the clinical translation of RNAi cancer therapeutics,...
Springer, 2023. — 949 p. This book highlights the role of Biomedical Engineering (BME) used in diagnosis (e.g., body scanners) and treatment (radiation therapy and minimal access surgery in order to prevent various diseases). In recent years, an important progress has been made in the expansion of biomedical microdevices which has a major role in diagnosis and therapy of...
Springer, 2019. — 681 p. This exhaustive work shows that new therapies using anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer, as tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. The first part of this book summarizes the knowledge acquired on the molecular entities that...
Springer Science+Business Media, New York, 2017. — 1087 p. — (Springer Reference) — ISBN: 1441907165. In the past decade, we have experienced an explosion of new information about cancer therapeutic targets. Many of the targets have been validated by the discovery and approval of new medicines which have been approved for the treatment of cancer. On the heels of these...
Academic Press, 2001. — 425 p. Tumor Suppressing Viruses, Genes, and Drugs profiles the new generation of cancer treatments now in development. The book examines the innovative new approaches of viral, gene, and signal therapies that promise to replace or enhance conventional methods such as surgery, radiation, and chemotherapy. The timely information presented by this book should...
Springer, 2023. — 418 p. — ISBN 978-3-031-40900-4. The field of kidney cancer has dramatically evolved over the past several years due to notable advances. Most importantly, systemic treatment options have expanded to include combination regimens for advanced disease and expansion of treatment options in the adjuvant setting. Additionally, surgical management has evolved...
Springer, 2019. — 129 p. The book provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chapters provide an overview and synthesis of the latest thoughts and findings relating to...
Springer, 2009. — 372 p. — ISBN: 978-0-387-89444-7 An estimated 1.5 million patients in the United States are diagnosed with cancer every year and over half-a-million individuals die of the disease. Since the vast majority of the deaths occur after medical intervention with anticancer therapy, both conventional chemotherapy and novel targeted therapy, it can be concluded that...
Springer International Publishing AG, 2018. — 281 p. — ISBN: 3319551124. This book provides a comprehensive overview of the clinical use of irreversible electroporation (IRE) - better known by its commercial name, NanoKnife - which is one of the most exciting new needle-guided cancer treatments. The coverage includes the history of IRE, general technique, preclinical research,...
Springer International Publishing AG, 2018. — 281 p. — ISBN: 3319551124. This book provides a comprehensive overview of the clinical use of irreversible electroporation (IRE) - better known by its commercial name, NanoKnife - which is one of the most exciting new needle-guided cancer treatments. The coverage includes the history of IRE, general technique, preclinical research,...
London: Academic Press, 2022. — 261 p. Combinational Therapy in Triple Negative Breast Cancer discusses TNBC at the molecular level from a holistic approach, focusing on combinational strategies targeting various pathways involved in this specific cancer type. Using a monotherapy for the treatment of cancer, especially high-grade tumors like TNBC, is mostly worthless due to the...
Springer, 2023. — 379 p. — ISBN 978-981-19-8910-0. This book highlights the interrelation between cell cycle regulators and breast cancer phenotypes. It reviews the roles of Cyclin-Dependent Kinases (CDK) in driving cell cycle progression, cell cycle checkpoints and dysregulation in breast cancer. It also examines the prognostic significance of CDKs in breast cancer. and CDK...
Springer, 2023. — 349 p. — ISBN 978-981-19-7549-3. This book illustrates the significance of probiotics and prebiotics for the management of various types of cancers. The up-to-date chapters provide recent information about the effect of anticancer treatment approaches on gut microbiota, the correlation between ROS and synbiotics for effective cancer treatment, and the...
Bentham Science Publishers, 2023. — 421 p. Nanotechnology has revolutionized cancer diagnosis and therapy through targeted drug delivery. Advances in protein engineering and materials science have led to the development of nanocarriers (NCs), which have helped overcome the challenges faced during conventional cancer treatment. These nanocarriers serve as an efficient transport...
Bentham Science Publishers, 2023. — 1085 p. — ISBN 978-981-5080-50-6. Nanotechnology has revolutionized cancer diagnosis and therapy through targeted drug delivery. Advances in protein engineering and materials science have led to the development of nanocarriers (NCs), which have helped overcome the challenges faced during conventional cancer treatment. These nanocarriers serve...
Humana, 2024. — 372 p. — ISBN-13 978-3031664205 Autophagy is a catabolic process that eliminates damaged and faulty cellular components via lysosomes. It responds to adverse circumstances like nutritional deficiency, hypoxia, and oxidative damage. Reactive oxygen species (ROS) cause oxidative stress, which is a multidimensional chemical that drives various pathophysiological...
Springer, 2025. — 246 p. — ISBN-13 : 978-9819610150 This book provides a comprehensive overview of the hypoxic tumor microenvironment and its impact on various aspects of cancer biology, including DNA damage response, genome instability, tumor immunity, non-coding RNA regulation, metabolic regulation of CAR-T cell function, and angiogenesis. It explores the regulation and...
Springer, 2023. — 452 p. — ISBN 978-981-99-0312-2. This book reviews the central role of hypoxia in cancer initiation and progression. It discusses the mechanisms of hypoxia in chemoresistance, radioresistance, angiogenesis, vasculogenesis, metastasis, metabolic, and genomic instability. It also explores the potential of hypoxia in the diagnosis and treatment of cancer. The...
Springer New York, 2014. — 322 p. Despite the advances in conventional, novel agent and high dose chemotherapy multiple myeloma (MM) remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in MM focusing on the development of...
MDPI, 2019. — 246 p. Polyamines are ubiquitous polycations essential for all cellular life. The most common polyamines in eukaryotes, spermine, spermidine, and putrescine, exist in millimolar intracellular concentrations that are tightly regulated through biosynthesis, catabolism, and transport. Polyamines interact with, and regulate, negatively charged macromolecules, including...
Academic Press, 2019. — 207 p. — (Cancer Sensitizing Agents for Chemotherapy). — ISBN: 978-0-12-817661-0. This book focuses on overriding the resistance from chemotherapeutic drugs with a broader range of treatment options. It particularly focuses on stroma, tumor microenvironment, stem cells, stellate cells, transcription factors, growth factors, and important signaling...
Springer, 2020. — 264 p. — (Diagnostics and Therapeutic Advances in GI Malignancies). — ISBN 978-981-15-5470-4. This book provides an up-to-date overview of gastrointestinal malignancies, including prevention, early detection, intervention, and life-extending therapeutics. It also assesses various biomarkers used for diagnostics, prognostics and prediction of response to...
1st Ed. Wiley, 2007. — 272 p Содержание Prologue Introduction: The Nature of the Beast Mario’s Story The First Hours The Plan Leukemia and Cancer Chemotherapy The Final Treatment Plan for Mario The Risk of Chemotherapy Resistance Three Critical Smart Drugs: Nursing Care, Psychology,and Social Work Mario’s Future Joan’s Story A Pleasant Summer Day Bad News An Initial Plan The...
Springer, 2020. — 266 p. — (Medical Radiology: Diagnostic Imaging). — ISBN: ISBN: 978-3-030-31170-4. This book is a detailed guide to therapy response imaging in cancer patients that fully takes into account the revolutionary progress and paradigm shift in treatment approaches for advanced disease. The opening chapters describe the role of imaging as a “common language” for...
Wiley-Blackwell, 2023. — 514 p. — ISBN 9781119819929. Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice focuses on lymphoma, an area which has seen a remarkable number of breakthroughs in the ongoing development of precision cancer therapies. Each section on a specific biology or class of drugs has an introductory chapter...
Wiley-Blackwell, 2023. — 2295 p. — ISBN 9781119819950. Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice focuses on lymphoma, an area which has seen a remarkable number of breakthroughs in the ongoing development of precision cancer therapies. Each section on a specific biology or class of drugs has an introductory chapter...
5th Edition. — Springer Science+Business Media B.V., 2009. — 743 p. — ISBN: 9048122775. At the time of the first edition of Principles of Cancer Biotherapy in 1987, this book represented the first comprehensive textbook on biological therapy. In 1991, when the second edition was published, there was still some doubt on the part of many oncologists and cancer researchers as to...
5th edition. — Wolters Kluwer, 2012. — 847 p. — ISBN: 978-1-451-10145-4 Perry’s The Chemotherapy Source Book , now in its fifth edition, provides information on the choice of chemotherapeutic agents, the use of combination chemotherapy, and the toxicity of individual drugs. Organized by site, this is the only book of its kind to focus strictly on the clinical practice of...
Springer Science & Business Media, 2007. — 476 p. Successful cancer chemotherapy relies heavily on the application of various deoxynucleoside analogs. Since the very beginning of modern cancer chemotherapy, a number of antimetabolites have been introduced into the clinic and subsequently applied widely for the treatment of many malignancies, both solid tumors and hematological...
Humana Press, 2018. — 402 p. — (Cancer Drug Discovery and Development). — ISBN 978-3-319-75834-3. Over the past decade a complex role for DNA damage response (DDR) in tumorigenesis has emerged. A proficient DDR has been shown to be a primary cause for cellular resistance to the very many DNA damaging drugs, and IR, that are widely used as standard-of-care across multiple cancer...
Bentham Science Publishers, 2017. — 220 p. Cancer is a major cause of deaths all around the globe. Although numerous anticancer drugs are available, most of them are expensive and have serious side effects. Natural compounds are usually non-toxic and inexpensive. Many such compounds have been identified and explored for their health benefits for centuries, and several...
Springer, 2023. — 313 p. — (Cancer Treatment and Research). — ISBN 978-3-031-27155-7. This comprehensive book provides an overview of cancer therapeutics and covers different innovative treatment approaches for cancer. The initial chapter gives a detailed overview on cancer progression and disease diagnostics. The following chapters focus on different cancer treatment...
Bentham Science Publishers, 2016. — 252 p. — ASIN B01M8NB6WW. The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to understand the molecular basis, both for inhibition and...
Sharjah: Bentham Science Publishers, 2016. — 167 p. Over the past decades, systems biology approaches have been applied in different areas of life science research including oncology. Researchers now understand the hallmarks of cancer cells such as abnormal cell growth, inflammation, dysregulated metabolic pathways and drug resistance properties at a molecular level. Systems...
Springer, 2022. — 620 p. — ISBN 978-981-19-5557-0. The nanotheranostics sector provides a very promising strategy for monitoring drug biodistribution and pathology longitudinal processes by integrating the imaging and drug delivery functions in one single nanoformulation, providing vital insights into the identification of tumour and predicting the efficacy of nanomedicine. For...
Springer International Publishing, 2015. — 248 p. — (Resistance to Targeted Anti-Cancer Therapeutics 5). — ISBN: 978-3-319-12729-3, 978-3-319-12730-9. Explores mechanisms of action in PDT, the relationship between PDT cytotoxicity and cellular changes Discusses the development of new technological advances in PDT for cancer Offers strategic approaches to reduce multi-drug...
Humana Press, 2010. — 627 p. — (Macromolecular Anticancer Therapeutics). — ISBN 978-1-4419-0506-2. The field of macromolecular therapeutics for cancer therapy is of considerable importance, as these therapeutic systems are gaining more and more interest to give new directions for the treatment of this dreadful disease. Macromolecular Anticancer Therapeutics, which describes in...
Springer Science & Business Media, 2010. — 568 p. Presenting a holistic and abstract perspective of tumors, this volume aims to provide personalized diagnostic and therapeutic strategies for the control of metastatic tumor disease. Readers will find ways to record tumor biology that are based on different sciences, in addition to other strategies.
De Gruyter, 2014. — 252 p. Peritoneal dissemination is a common route of cancer metastasis. The benefit of administering chemotherapy directly into the peritoneal cavity is supported by preclinical and pharmacokinetic data. In comparison to intravenous (IV) treatment, intraperitoneal (IP) administration results in a several-fold increase in drug concentration within the...
Rutgers University Press, 2019. — 122 p. Precision medicine is rapidly becoming the standard-of-care for the treatment of cancer patients. This is made possible, in part, by the ready availability and reasonable costs of comprehensive DNA and RNA sequencing assays. However, precision medicine is complex and incorporates entirely new types of data and treatment paradigms that...
CRC Press, 2024. — 287 p. — ISBN 9781032379364. New research is being conducted in the diagnosis and new treatments of cancer that has high efficacy and are minimally invasiveness. Artificial intelligence, bioimpedance, thermal images and nanomaterials have been used to provide early diagnosis. New treatments based on the generation of microwaves, radiofrequency, or ultrasound...
Springer, 2013. — 311 p. The literature on the late effects of cancer treatment is widely scattered in different journals since all major organ systems are affected and management is based on a variety of medical and surgical treatments. The aim of "ALERT – Adverse Late Effects of Cancer Treatment" is to offer a coherent multidisciplinary approach to the care of cancer survivors....
Springer Berlin Heidelberg, 2016. — 700 p. The literature on the late effects of cancer treatment is widely scattered in different journals since all major organ systems are affected and management is based on a variety of medical and surgical treatments. The aim of "ALERT – Adverse Late Effects of Cancer Treatment" is to offer a coherent multidisciplinary approach to the care of...
New York: Humana Press, 2015. — 269 p. — (Current Clinical Pathology). — ISBN: 978-1-4939-2046-4, 978-1-4939-2047-1. This volume provides readers a comprehensive and state-of-the-art overview about the range of applications of targeted therapies for solid tumors. The sections of the book have been structured to review the oncogene addicted tumors, the pharmacology and clinical...
Springer, 2014. — 349 p. Since the discovery of microRNAs (miRNAs) some twenty years ago by Victor Ambros, David Baulcombe and Gary Ruvkun, these three scientists worked to uncover the mystery of miRNA, the small segments of nucleotides that silence genes. While studying the development of the nematode worm, Ambros and Ruvkun discovered miRNA in animals, while Baulcombe discovered...
Humana Press Inc., 2007. — 455 p. — ISBN: 978-1-58829-672-6. Regional cancer therapies remain important options in the management of malignant disease, in spite of the venue of more targeted agents for systemic therapies. New technologies and better guidance systems for radiofrequency ablation and intrastitial laser therapies, highly selective intravascular approaches with...
Springer, 2022. — 588 p. — ISBN 978-3-030-98595-0. This book fills an important gap in the professional’s daily practice of both Oncology and Hematology. From the understanding of oncological and hematological diseases, drugs and protocols, to the administration of an oncology pharmacy, this book is an essential guide to supporting health professionals working or that intend to...
Springer Science & Business Media, 2007. — 284 p. Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of...
CRC Press, 2018. — 185 p. This book is an introduction to cancer treatment, the basics of radio- and chemotherapy, drug actions, the eradication of cancer cells, and the origins and persistence of pharmacological and toxicological effects of drugs. It further provides ideas for research based on knowledge of cancer metastasis, invasive and molecular pathways, and diagnosis and...
Wiley, 2024. — 554 p. Understand the use of heat to destroy tumors with this comprehensive guide Heat is an indispensable resource in the destruction of cancerous tumors to potentially treat cancers. There are also real challenges, however, involved in the total destruction of tumors without destroying healthy tissue surrounding the tumor in the process. A detailed...
Humana Press, 2005. — 343 p. Bone metastasis occurs in 60 to 85% of all breast, prostate, and lung cancer patients and is responsible for increasing morbidity. In Bone Metastasis: Experimental and Clinical Therapeutics, leading bone metastasis experts from around the world explain the molecular underpinnings of the process, review current treatment approaches, and outline...
Lippincott Williams & Wilkins, 2011. — 889 p. Skeel's Handbook of Cancer Chemotherapy combines in one place the most current rationale and specific details necessary to safely administer chemotherapy for most adult cancers. The handbook is a practical, diseased-focused pocket reference that emphasizes the best current medical practice as it relates to the delivery of...
5th edition. — Wolters Kluwer, 2022. — 1935 p. — ISBN 9781975162016. Offering comprehensive coverage of the clinical, physical, and technical aspects of radiation treatment planning, Khan’s Treatment Planning in Radiation Oncology, Fifth Edition, provides a team approach to this complex field. Drs. Paul W. Sperduto and John P. Gibbons are joined by expert contributing authors...
New York: Springer, 2006. — 143 p. In the age of the World Wide Web, informed patients continue to surprise oncologists with detailed questions about popular tumor therapies. Although minimally invasive tumor therapies (MITT) have become daily clinical practice for palliative treatment of liver tumors, the acceptance of these palliative modalities still varies enormously. In...
Fachmedien: Springer, 2015. — 126 p. — ISBN: 978-3-658-09504-8, 978-3-658-09505-5. Georg Stuebinger verifies each of the 24 most common and deadliest cancer diseases worldwide including well-established and potential risk factors resp. important symptoms by using current literature and comprehensive scientific studies with a direct relation to the impact of various parameters...
CRC Press, 2003. — 415 p. The growth in chemotherapy has led to a great need for all those involved to be familiar with safe procedures based on best evidence-based practice. Practical Chemotherapy: a multidisciplinary guide is a comprehensive and straightforward guide describing over 70 widely used chemotherapy regimens, helping to make their prescription and administration...
CRC Press, 2017. — 117 p. This comprehensive and useful handbook represents a definitive up-to-date compendium of key in vitro bioassay methods that are employed to quantify and validate the anticancer activity of a drug candidate before it makes its way in to animal or clinical trials. In Vitro Bioassay Techniques for Anticancer Drug Discovery and Development covers the screening...
Humana Press, 2008. — 585 p. — ISBN: 978-1-58829-870-6. Angiogenesis as a therapeutic target for malignant disease has evolved from a pioneering idea outside of the mainstream of therapeutic development to an FDA-approved therapy widely used in patients with metastatic disease. The success in achieving such rapid progress in realizing the importance of angiogenesis in tumor...
World Scientific, 2009. — 201 p. — ISBN: 978-981-283-579-6 This very provocative book takes the reader on a “think-out-of-the-box” journey through the development of a treatment regimen for multiple myeloma called “dtZ”. It is a firsthand account of how more than 50 patients with myeloma were given a non-toxic, precisely-targeted, anti-cancer treatment that was specifically...
M.Teppone, R.Avakyan. Extremely High-Frequency Therapy in Oncology. - The Journal of Alternative and Complementary Medicine. 2010, 16(11): 1211-1216.
Objective: This article represents a review of the literature, mainly from Russian sources, dealing with the therapeutic application of low-intensity electromagnetic radiation in the millimeter band applied to experimental and...
Hoboken, New Jersey: Wiley-Blackwell, 2015. — 400 p. — ISBN: 400-978-1-118-46857-9, 1118468570. Targeted Therapy in Translational Cancer Research for the Translational Oncology series provides a comprehensive overview of recent developments in our understanding of tumor biology, elucidates the roles of targets and pathways involved in carcinogenesis, and describes current...
Springer, 2023. — 283 p. This book describes translational cancer therapeutics and the way forward from clinical and molecular diagnosis to treatment. In addition, genomics alterations, microRNAs, and long non-coding RNAs translate precision medicine for the individualistic therapy of cancer patients. It describes the involvement of various pharmacogenetic factors in...
Boca Raton: CRC Press, 2021. — 362 p. In the last decade the use of interstitial microwave antennas to deliver localized and controlled power to deep-seated tumours has been explored in institutes around the world. Simultaneously the field of brachytherapy also progressed as clinicans began to develop new implantation approaches for a variety of tumour sites, thereby promoting...
Springer, 2018. — 183 p. — ISBN: 978-3-319-61871-5. The management of multiple myeloma (MM) has evolved tremendously over the last decade, from being an orphan disease with limited treatment options to a disease that can be chronically managed for most patients. The knowledge of the heterogenous disease biology and development of novel drug classes (immunomodulatory drugs,...
2nd edition. — Hoboken: Wiley, 2024. — 453 p. Demystifying the science behind new cancer treatments An accessible guide written in everyday language for nurses and non-scientists Written by gifted communicator Elaine Vickers, PhD, this is the second edition of her popular book, first published in 2018. Since then, hundreds of readers have benefited from Elaine's informal style,...
Wiley-Blackwell, 2018. — 346 p. — ISBN: 978-1-119-12679-9 Written for anyone who encounters cancer patients, cancer data or cancer terminology, but have no more than a passing knowledge of cell biology. A Beginner's Guide to Targeted Cancer Treatments provides an understanding of how cancer works and the many new treatments available.Using over 100 original illustrations, this...
Wiley-Blackwell, 2018. — 1106 p. — ISBN: 978-1-119-12682-9 Written for anyone who encounters cancer patients, cancer data or cancer terminology, but have no more than a passing knowledge of cell biology. A Beginner's Guide to Targeted Cancer Treatments provides an understanding of how cancer works and the many new treatments available.Using over 100 original illustrations, this...
Springer, 2019. — 285 p. — (Cancer Treatment and Research) — ISBN: 978-3-030-16390-7 This book presents the latest advances in precision medicine in some of the most common cancer types, including hematological, lung and breast malignancies. It also discusses emerging technologies that are making a significant impact on precision medicine in cancer therapy. In addition to...
McGraw-Hill, 2005. — 228 p. Inspired by the experience of art therapists who have pioneered work with people with cancer and including those who have experienced this devastating illness at first hand, this book acknowledges the outstanding work of the Corinne Burton Trust which has supported the development of art therapy services in hospices and clinics throughout the United...
Springer, 2016. — 139 p. — ISBN: 978-3-319-30574-5 This concise text provides a complete overview of alternating electric fields therapy -- also known as tumor treating fields -- for glioblastoma and other types of solid tumor malignancies. Readers are given a fundamental understanding of this novel anti-cancer treatment modality by learning from clinical trial data as well as the...
Springer Publishing Company, 2016. — 192 p. Cancer Pharmacology and Pharmacotherapy Review is the first book devoted entirely to providing the 'must-know' facts on each cancer agentóincluding their pharmacokinetics, FDA-approved indications, toxicity, interactions, and other important information that is commonly found on board examinations and essential for any clinician or...
Springer Publishing Company, 2016. — 192 p. Cancer Pharmacology and Pharmacotherapy Review is the first book devoted entirely to providing the 'must-know' facts on each cancer agentóincluding their pharmacokinetics, FDA-approved indications, toxicity, interactions, and other important information that is commonly found on board examinations and essential for any clinician or...
Springer International Publishing, Switzerland, 2016, 141 pages, ISBN: 978-3-319-42738-6, 978-3-319-42740-9. Current Cancer Research. Focuses solely on autophagy as a target in cancer therapy, for the first time. Covers a wide range of topics such as autophagy as a therapeutic target in cancer, autophagy modulators as cancer therapeutic agents, implications of...
Springer, 2023. — 333 p. — (Cancer Treatment and Research). — ISBN 978-3-031-30064-6. This book discusses the latest developments in Poly (ADP-ribose) polymerase (PARP) inhibitor drug development. It focuses on the translational and clinical development of the latest drugs, as well as the evidence for regulatory approval of PARP inhibitors in multiple different molecular...
Руководство для врачей. — СПб.: СпецЛит, 2018. — 286 с. — ISBN: 978-5-299-00912-5. Данное издание - первое в России практическое руководство по применению высокотехнологичных методов регионарной химиотерапии в комплексном лечении больных с местнораспространенными и метастатическими злокачественными новообразованиями. Оно основано на много летнем клиническом опыте специалистов...
Женева: ВОЗ, 1996. — 82 с.
Во многих частях мира большинство больных раком обращаются за медицинской помощью на далеко зашедшей стадии болезни, и единственными ведами лечения, которые они реально могут получить, остаются облегчение болей и паллиативная терапия. В 1986 г. в первом издании этой книги был предложен метод обезболивания при раке, основанный на применении небольшого...
М. : Эксмо, 2011. — 480 с. Онкологи считают, что у взрослых людей около трети видов рака связано с питанием. Но еда может и уменьшить опасность заболевания, и повлиять на рост опухоли на разных этапах. Например, те, кто ест больше всего фруктов и овощей, в два раза реже болеют раком, чем те, кто их ест мало. Наша книга будет полезна не только тем, кто заботится о своем...
2-е издание, переработанное и дополненное. — Киев: Наукова думка, 1991. — 304 с. — ISBN 5-12-001887-4. Институт проблем онкологии им. Р.Е. Кавецкого. В справочнике обобщены и систематизированы сведения из отечественной и зарубежной литературы, а также собственные данные о биологических и фармакологических свойствах и противоопухолевом действии 58 антибластических веществ,...
М.: Агат-Мед., 2001. - 110 с. Представлены современные данные, характеризующие особенности опухолевого роста, от которых зависит реакция на лекарственные препараты. Каждый очерк представляет собой законченный анализ определенных проблем, связанных с разработкой новых направлений противоопухолевой терапии. Состоит из 4-х очерков: Апоптоз и его в развитии опухолевого роста....
Монография. – 2-е изд., перераб. и доп. – М.: Медицина, 1986. – 288 с. В книге описана система симптоматической терапии больных с распространенными формами злокачественных новообразований при невозможности проведения или исчерпанных возможностях специального противоопухолевого лечения. По сравнению с предыдущим изданием (1980) расширены разделы, посвященные симптоматическому...
Монография. — 2-е изд., перераб. и доп. —М.: Медицина, 1986. — 288 с. В книге описана система симптоматической терапии больных с распространенными формами злокачественных новообразований при невозможности проведения или исчерпанных возможностях специального противоопухолевого лечения. По сравнению с предыдущим изданием (1980) расширены разделы, посвященные симптоматическому...
М.: Литтерра, 2008. — 44 с. Профилактика и борьба с осложнениями противоопухолевого лечения получила название сопроводительной или поддерживающей терапии. Задачей этой книги является ознакомление врачей с основными алгоритмами и принципами сопроводительного лечения, направленного на борьбу в наиболее частыми, а нередко и наиболее опасными осложнениями цитостатической терапии:...
Москва: Федеральный медицинский исследовательский центр имени П.А. Герцена, 2015. — 49 с. Методические рекомендации Авторы: Каприн А.Д., Абузарова, Хороненко В.Э., Алексеева Г.С., Костин А.А., Старинский В.В., Алексеев Б.Я. В соответствии с рекомендациями Всемирной организации здравоохранения и международными рекомендациями по паллиативной медицине, основным методом контроля...
М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «ФМИЦ им. П.А. Герцена» Минздрава России, 2015. — 48 с. В методических рекомендациях приведены правила фармакотерапии болевого синдрома у онкологических больных с учетом особенностей перечня опиоидных анальгетиков» зарегистрированных в России. В соответствии с рекомендациями Всемирной организации здравоохранения и Европейскими...
Учебное пособие. — Самара: СамГМУ, 2015. — 33 с. В пособии представлены сведения о современных возможностях малоинвазивной диагностики и лечения в онкологии. Описаны методы флуоресцентной диагностики и фотодинамической терапии. Приведены сведения о истории развития метода, его сущности и современных возможнастях, сформулированы показания и противопоказания для применения....
Издательские решения, 2018. — 86 с. Эта книга поможет оптимальным образом справиться с токсическими побочными эффектами лечения и узнать, как лучше контролировать проблемы со здоровьем, возникающие в повседневной жизни во время лечения у онколога, чтобы результативнее справляться с болезнью. Это бесценный путеводитель для всех пациентов, которые найдут в нем эффективный подход и...
Издательские решения, 2018. — 75 с. Эта книга поможет оптимальным образом справиться с токсическими побочными эффектами лечения и узнать, как лучше контролировать проблемы со здоровьем, возникающие в повседневной жизни во время лечения у онколога, чтобы результативнее справляться с болезнью. Это бесценный путеводитель для всех пациентов, которые найдут в нем эффективный подход и...
СПб.: СПбГМУ, 2006. — 39 с. Диагностика множественной миеломы и выбор оптимальной тактики лечения остается актуальной проблемой современной гематологии. В рамках данного пособия представлены современные сведения об особенностях клинических проявлений, принципах диагностики, выборе метода лечения, контроле эффективности проводимой терапии у больных множественной миеломой....
Без выходных данных. 11 с. Рекомендации для пациентов, проходящих курс химиотерапии: как готовиться к процедуре, как наблюдать за общим самочувствием, советы по корректировке образа жизни, питания и т.д.
Монография. — Архангельск: Поморский университет, 2005. — 128 с. — ISBN: 5-88086-534-7. Монография посвящена актуальным проблемам психосоциальной поддержки инкурабельных онкологических пациентов в терминальный период заболевания. Специфическая динамика психосоциальной ситуации, связанная с этим периодом, обуславливает изменение жизненных целей и мотивов, изучение и коррекция...
3-е изд., доп. и пер. — М.: Практическая медицина, 2011. — 512 с. — ISBN: 978-5-98811-180-1. Настоящее издание классического руководства по химиотерапии (предыдущее издание вышло в 2005 г.) полностью переработано и дополнено информацией о новых противоопухолевых лекарственных средствах, вошедших в клиническую практику за последние 5 лет, в частности о молекулярно-нацеленных...
3-е изд., доп. и пер. — М.: Практическая медицина, 2011. — 512 с. — ISBN: 978-5-98811-180-1. Настоящее издание классического руководства по химиотерапии (предыдущее издание вышло в 2005 г.) полностью переработано и дополнено информацией о новых противоопухолевых лекарственных средствах, вошедших в клиническую практику за последние 5 лет, в частности о молекулярно-нацеленных...
Учебное пособие. — М.: Российская медицинская академия непрерывного профессионального образования, 2017. — 52 с. — ISBN 978-5-7249-2846-5. Цель учебного пособия — систематизировать данные по лекарственной терапии нейроэндокринных опухолей. Содержание пособия соответствует содержанию образовательной программы высшего образования — подготовке кадров в ординатуре и дополнительной...
Комментарии